In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way drugeruptiondata.com uses cookies please read our 'Cookie Policy'.
Adverse reactions attributed to entire drug class 'Selective serotonin reuptake inhibitor (SSRI)'
Please login to view adverse reactions.
- (2018): Quagliato LA+, Expert Opin Drug Saf Jan, Epub ahead of print [REVIEW]
- (2016): Nezafati MH+, J Res Med Sci 21, 66 [REVIEW]
Cardiovascular adverse effect (includes major adverse cardiovascular events (MACE))
- (2023): Chen Y+, Psychiatry Res Jun, Online ahead of print
- (2019): Humbert X+, Fundam Clin Pharmacol 33(3), 296-3023% [REVIEW]
QT interval prolonged / QT prolongation
- (2014): Beach SR+, J Clin Psychiatry 75(5), e441 [REVIEW]
- (2016): Romero J+, J Interv Card Electrophysiol 45(1), 37
- (2014): Prescrire Int 23(150), 153 [REVIEW]
- (2015): Hawthorne JM+, Ann Pharmacother 49(10), 1136 [REVIEW]
- (2015): Zadori D+, Expert Opin Drug Saf 14(6), 877 [REVIEW]
- (2014): Kogoj A, Psychiatr Danub 26(3), 277 [REVIEW]
- (2015): Hawthorne JM+, Ann Pharmacother 49(10), 1136 [REVIEW]
- (2015): Hawthorne JM+, Ann Pharmacother 49(10), 1136 [REVIEW]
- (2018): Luft MJ+, Curr Probl Pediatr Adolesc Health Care 48(2), 50 (impulsivity)
- (2015): Hawthorne JM+, Ann Pharmacother 49(10), 1136 [REVIEW]
Restless legs syndrome / Willis-Ekbom disease (includes restless arms syndrome variant)
- (2015): Zadori D+, Expert Opin Drug Saf 14(6), 877 [REVIEW]
- (2018): Luft MJ+, Curr Probl Pediatr Adolesc Health Care 48(2), 50
- (2014): Maguire MJ+, Cochrane Database Syst Rev 12, CD010682 [REVIEW]
- (2017): Bartlett D, Crit Care Nurse 37(1), 49
- (2015): Nguyen T+, Consult Pharm 30(8), 455
- (2015): Zadori D+, Expert Opin Drug Saf 14(6), 877 [REVIEW]
- (2013): Dobry Y+, Int J Adolesc Med Health 25(3), 193 [REVIEW]
- (2016): Sarosiek I+, Expert Opin Drug Saf 15(7), 937 [REVIEW]
- (2015): Zadori D+, Expert Opin Drug Saf 14(6), 877 [REVIEW]
- (2015): Zadori D+, Expert Opin Drug Saf 14(6), 877 [REVIEW]
- (2016): Sarosiek I+, Expert Opin Drug Saf 15(7), 937 [REVIEW]
- (2014): Maguire MJ+, Cochrane Database Syst Rev 12, CD010682 [REVIEW]
- (2012): Letmaier M+, Int J Neuropsychopharmacol 15(6), 739
- (2018): Quagliato LA+, Expert Opin Drug Saf Jan, Epub ahead of print [REVIEW]
- (2016): Sarosiek I+, Expert Opin Drug Saf 15(7), 937 [REVIEW]
- (2018): Quagliato LA+, Expert Opin Drug Saf Jan, Epub ahead of print [REVIEW]
- (2016): Sarosiek I+, Expert Opin Drug Saf 15(7), 937 [REVIEW]
- (2016): Sarosiek I+, Expert Opin Drug Saf 15(7), 937 [REVIEW]
- (2014): Maguire MJ+, Cochrane Database Syst Rev 12, CD010682 [REVIEW]
Pancreatitis / acute pancreatitis
- (2018): Quagliato LA+, Expert Opin Drug Saf Jan, Epub ahead of print [REVIEW]
- (2023): Lalegani E+, Brain Sci 13(10), 1397
- (2022): Valeiro C+, Drug Saf Apr, Online ahead of print
- (2018): Quagliato LA+, Expert Opin Drug Saf Jan, Epub ahead of print [REVIEW]
- (2016): Sarosiek I+, Expert Opin Drug Saf 15(7), 937 [REVIEW]
- (2015): Zahiroddin A+, Iran Red Crescent Med J 17(12), Epub
- (2014): Kemp DE, J Affect Disord 169 Suppl 1, S34 [REVIEW]
- (2014): Maguire MJ+, Cochrane Database Syst Rev 12, CD010682 [REVIEW]
- (2013): Giuliano F+, Prog Urol (French) 23(9), 804
- (2015): Hawthorne JM+, Ann Pharmacother 49(10), 1136 [REVIEW]
- (2015): Zadori D+, Expert Opin Drug Saf 14(6), 877 [REVIEW]
Myoclonus (see also hypnic jerk)
- (2015): Zadori D+, Expert Opin Drug Saf 14(6), 877 [REVIEW]
- (2013): Zofkova I, Vnitr Lek (Czech) 59(1), 59 [REVIEW]
- (2015): Lochhead J, Eye (Lond) 29(9), 1233 (5 cases)
Adverse effects / adverse reactions
- (2024): Zhao Y+, Ann Pharmacother Feb, Online ahead of print (pharmacovigilance)
- (2015): Mortensen JK+, Expert Opin Drug Saf 14(6), 911 [REVIEW]
